Bullish Analyst Sentiment on Wix.com (WIX) Despite CFRA's Lowered Target and Slower Growth Outlook

Wix.com Ltd. (NASDAQ:WIX) is one of the 15 best AI stocks to watch in December 2025.

As of December 8, 2025, roughly 90% of analysts remain bullish on Wix.com Ltd. (NASDAQ:WIX) with a median price target of $170.00. The consensus price target implies 70% upside.

The most recent analyst commentary came from CFRA on November 24, 2025, where the firm reiterated its “Buy” rating but lowered its price target from $200 to $140. With slower revenue growth expected through 2026, the firm projects a two-year revenue CAGR of 13%, compared with a five-year CAGR of 18% through 2024.

Nevertheless, CFRA projects premium subscriptions will continue to grow, driven by ongoing product enhancements and marketing initiatives targeting high-intent users. Moreover, the investment firm expects Wix.com Ltd. (NASDAQ:WIX) to achieve higher average revenue per subscription through increased product pricing, a shift toward higher-priced plans, broader product offerings, and greater adoption of Business Solutions features.

Amid pressure from increased investments in AI, product development, and scaling and integration of Base44, CFRA expects modest operating margin compression in 2025 and 2026. However, it expects operational efficiency efforts and cost-management initiatives to partially offset these margin headwinds. While CFRA maintained its 2025 non-GAAP EPS estimate of $7.43, it lowered its 2026 EPS forecast from $8.75 to $7.82. The reduced EPS forecast reflects revised margin expectations associated with higher anticipated investment spending.

Operating a cloud-based website design and development platform, Wix.com Ltd. (NASDAQ:WIX) offers web templates, a web editor, a web builder, search engine optimization tools, a logo maker, web hosting, and email marketing services.

While we acknowledge the potential of WIX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 Best Small-Cap Biotech Stocks to Buy According to Analysts and 11 Overlooked Tech Stocks to Invest In.

Disclosure: None.